Abderrahim Fandi

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Giuseppe Giaccone, Roy S. Herbst, Christian Manegold et al. · Journal of Clinical Oncology · 2004 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +13

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller et al. · Journal of Clinical Oncology · 2004 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Primo N. Lara, Jean‐Yves Douillard, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology · 2011 · 320 citations · Full text

Medicine, Oncology, Pharmacology +16

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer

Erminia Massarelli, Fabrice André, D. D. Liu et al. · Lung Cancer · 2002 · 201 citations

Medicine, Oncology, Chemotherapy +9

Nasopharyngeal cancer: epidemiology, staging, and treatment.

Abderrahim Fandi, Musa Altun, N Azli et al. · PubMed · 1994 · 187 citations

Medicine, Oncology, Otolaryngology +12